Clinical Trial Update: PD-1 Inhibitor INCMGA00012 as Consolidation Therapy After Definitive Concurrent Chemoradiotherapy [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial investigating the PD-1 inhibitor INCMGA00012 as consolidation therapy after definitive concurrent chemoradiotherapy for esophag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• INCMGA00012

Snippet

Sponsor: Asan Medical Center | Conditions: Esophageal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING